chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Had started with some issues but it got way worse, Narcolepsy, type 1 w/cataplexy and went to ER late nigh with admission to hospital for 3 days, ongoing for symptoms.
felt a little bad on the day patient had his 2nd Covid-19 vaccine; This is a spontaneous report from a non-contactable consumer (patient) received by Pfizer from Novartis. A 45-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19  VACCINE, Solution for injection; lot number and expiration date: not reported), via an unspecified route of administration, on an unspecified date, as DOSE 2, SINGLE for covid-19 immunization . The patient's medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiration date: not reported), via an unspecified route of administration, on an unspecified date, as DOSE 1, SINGLE for covid-19 immunization. The patient felt a little bad on the day he had his 2nd covid-19 vaccine (on an unspecified date). The outcome of the event was unknown at time of report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
This spontaneous report as received from a registered nurse refers to unspecified number of patients of unknown age and gender. Medical history and concurrent conditions were not reported. On an unknown date the patients were vaccinated with ROTATEQ oral, lot # K011947, expiration ate 07-JUN-2016, Lot K020181 expiration date 24-JUN-2016, Lot K019370 expiration 16-JUL-2016 (dose was not reported). The vaccines underwent supported temperature excursions. No adverse effects reported. This is one of several reports from the same source. Additional information has been requested.
Since receiving the 1st Moderna vaccine in my left upper arm, my left arm below the injection site has been extremely itchy. It got even itchier after the 2nd vaccine 4 weeks later. Even today on 2/18/21 my left arm still itches and the skin is becoming rough and sensitive.
pt became very anxious with sob and chest tightness. O2 sat 99. No distress
20 minutes after vaccination, I felt light-headed, nauseous, left arm became sore, felt dizzy, felt feverish and weak.
lymph node swelling under left armpit; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37 year-old patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 10Apr2021 11:00 (Lot number: EW0153) at the age of 37 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: LYMPHADENOPATHY (non-serious), outcome "recovered", described as "lymph node swelling under left armpit". Therapeutic measures were not taken as a result of lymphadenopathy.  Additional information: Anatomical Site of injection: Left upper arm. Within 3-5 days of injection, lymph node swelling under left armpit occurred and lasted 3-5 days after each of the 3 injections. No other events occurred, no medical treatment was sought.  Follow-up attempts are completed. No further information is expected.
per mom about 45mins to an hr p/vax pt exp vomiting,pallor,fever to 103,chills,drowsiness,slept intermittently&was able to be aroused;mom was unable to give recommended non-ASA prophylactic Re: DTP d/t vomiting;pt seen in ER w/t104.7
wiped out and felt tired; arm hurt; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP).  An 82 year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administered in left arm, administration date 26Feb2021 10:00 (Batch/Lot number: unknown) at the age of 82 years, as dose number unknown, single for COVID-19 immunisation. Relevant medical history included: "atrial fibrillation" (ongoing); "high blood pressure" (ongoing). Concomitant medication included: METOPROLOL taken for atrial fibrillation, hypertension, start date: 2018 (ongoing). The following information was reported: FATIGUE (non-serious) with onset 26Feb2021, outcome "recovered" (27Feb2021), described as "wiped out and felt tired"; PAIN IN EXTREMITY (non-serious) with onset 26Feb2021, outcome "recovered" (27Feb2021), described as "arm hurt". Therapeutic measures were taken as a result of pain in extremity. Additional information: Paracetamol (TYLENOL) was taken for the event "arm hurt".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report was received from a registered nurse and refers to a 12 month old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 03-AUG-2017, the patient was vaccinated with an improperly stored VARIVAX at a dose of 0.5 (units not specified) from lot # N012132 with expiry date: 17-APR-2019 (dose number, route, anatomical location and site of administration were not reported) for prophylaxis. Concomitant medications included a properly stored sterile diluent (manufacturer unknown). The administered dose of vaccine was stored in the temperature between 6 degrees Fahrenheit and 14 degrees Fahrenheit for 20 hours and in the temperature between 15 degrees Fahrenheit and 46 degrees Fahrenheit for 6 hours. There were no previous temperature excursions. Data logger was involved. No adverse effects were reported. No additional information was provided. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1707USA004945.
1 cm nodule with overlying redness on Right anterior thigh. 0.5 cm nodule with overlying redness on Left anterior thigh.
Breakout infection of COVID-19 with mild-to-moderate symptoms, including high fever, severe chills, body and joint aches, severe headache, chest and nasal congestion, sore throat.
On about 1/21/21 I developed a three-inch in diameter red circle on my left arm where I received the vaccine. It is swollen, warm and itchy.
The morning after receiving my vaccine I woke up with a mild fever, chills and achy muscles.  That lasted all day.  Then the 3rd morning I woke and noticed that about an inch under my injection site, I had a raised welt.  It was very sore to the touch and also occasionally itchy.
3 hours after vaccine had chills, fatigue, flush face, and body aches- only lasted about 4 hours. But the next day had chest pain and heart palpitations
3:39 client reported being dizzy ps02 100% b/p 170/82  pulse 86 water given and monitored.   Then reported that her tongue was thick and lips tingling.   3:42 b/p 218/90 pulse 120 skin pink warm and dry. Respirations even and unlabored, placed in wheel chair and at 3:52 exited the building to ER
Shortly after receiving Defendants' Zostavax vaccine, Plaintiff suffered shingles.; Information has been received from a lawyer and the patient (pt) regarding a case in litigation involving a female patient (pt) of unknown age. No information about the pt's pertinent medical history, concomitant medications and drug reactions or allergies was provided.  In or around October 2016, the pt was inoculated with a dose of zoster vaccine live (ZOSTAVAX) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster) (strength, route, frequency, lot/batch # and expiration date were not reported). Shortly after receiving zoster vaccine live (ZOSTAVAX), the pt suffered shingles (herpes zoster). As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the pt's symptoms had resulted in physical limitations not present prior to using it. The pt also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of the manufacture, marketing, advertising, promotion, distribution, and/or sale of zoster vaccine live (ZOSTAVAX), the pt sustained severe and permanent personal injuries. Further, as a tragic consequence the pt suffered serious, progressive, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. The reporter considered the event to be related to zoster Vaccine Live (ZOSTAVAX). The reporter considered the event to be disabling.
12/12/21 presents to ED for "worsening cough and SOB". PMHx of "prior DVT, HLD".
HEADACHES; HEART RATE INCREASED; FEELING HOT; SORE LEFT ARM AND LEGS ACHY; CHILLS; FEELING WEAK; This spontaneous report received from a patient concerned a 23 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 207A212A expiry: UNKNOWN) dose was not reported, administered on 05-MAY-2021 18:15 for prophylactic vaccination. No concomitant medications were reported. On 06-MAY-2021, the subject experienced heart rate increased. On 06-MAY-2021, the subject experienced feeling hot. On 06-MAY-2021, the subject experienced sore left arm and legs achy. On 06-MAY-2021, the subject experienced chills. On 06-MAY-2021, the subject experienced feeling weak. On 06-MAY-2021 04:00, the subject experienced headaches. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from heart rate increased, had not recovered from feeling hot, headaches, sore left arm and legs achy, and feeling weak, and the outcome of chills was not reported. This report was non-serious.
This is a prospective pregnancy case. This 27-year-old female subject was enrolled in a study. The subject received FLUARIX (injection) on 6th October 2014. The subject's estimated date of delivery was 3rd March 2015. The subject received FLUARIX at week 19 of the pregnancy and during the second trimester of pregnancy. On 6th October 2014, an unknown time after receiving FLUARIX the subject developed vaccine exposure during pregnancy (Non-serious). The outcome of vaccine exposure during pregnancy was unknown. The pregnancy was ongoing.
Arm rash for a week; Fever; Chills; Nausea; Lymph nodes, around my neck is swollen. it is not severe; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Arm rash for a week), PYREXIA (Fever), CHILLS (Chills), NAUSEA (Nausea) and LYMPHADENOPATHY (Lymph nodes, around my neck is swollen. it is not severe) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     The patient's past medical history included Pneumonia.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced RASH (Arm rash for a week), PYREXIA (Fever), CHILLS (Chills), NAUSEA (Nausea) and LYMPHADENOPATHY (Lymph nodes, around my neck is swollen. it is not severe). On 23-Apr-2021, PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea) had resolved. On 29-Apr-2021, RASH (Arm rash for a week) had resolved. At the time of the report, LYMPHADENOPATHY (Lymph nodes, around my neck is swollen. it is not severe) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Pt recvd 3 doses of Engerix-B vax on 8NOV90, 26NOV90, 29APR91 & 1OCT91 it was determined that pts titer was neg p/3 doses of Engerix-B;
Fatigue, nausea, muscle & joint pain, headache, fever/chills starting at approximately 10:00pm on 4/20/21. All symptoms resolved 07:30am 4/22/21 other than headache.
5hr p/vax pt was crying very hard;suddenly devel cyanosis below the waist only which resolved p/40min (long p/crying stopped);cyanosis was observed by MD also devel urticaria on hand;
Redness and swelling at site of injection, size of a baseball, warm to the touch.
Information has been received from an office manager concerning a 47 year old female with iodine allergy who on 21-SEP-2007 was vaccinated SC with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (lot #657525/0554U). On approximately 24-SEP-2007 the patient developed cellulitis at the injection site. On 24-SEP-2007 the patient called the physician's office. The patient was treated with cephalexin (KEFLEX). At the time of the report, the patient had not recovered. The office manager is requesting a lot check. A standard lot check was performed. All in-process quality checks for the lot number in question were satisfactory. In addition, an expanded lot check investigation was performed. The testing performed on the batch prior to release met all release specifications. The lot met the requirements of the Center for Drug Evaluations and Research and was released. Additional information has been requested.
injection site very  swollen; injection site very red; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (injection site very  swollen) and INJECTION SITE ERYTHEMA (injection site very red) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE SWELLING (injection site very  swollen) and INJECTION SITE ERYTHEMA (injection site very red). At the time of the report, INJECTION SITE SWELLING (injection site very  swollen) and INJECTION SITE ERYTHEMA (injection site very red) outcome was unknown.            No concomitant medications were reported.  No treatment medications were provided by the reporter.
Patient received the Pneumovax 23 shot on 10/23/19 and starting having intense pain that was about below the entire arm of the injection sute. Half of his arm was in severe pain. He started bruising and started having skin discoloration. No itching. This started the night after receiving the shot from the pharmacy. Pt ended up in the urgent care clinic where he received steroid shot, Bactrim BD, prednisone tabs, and something for itching which he didn't remember the name. V=
Two weeks after the first dose started having sudden dizziness, lightheadedness and some headaches. Another big spike one week after the second dose. Sometimes gets better, sometimes worse, but never completely went away
Presented to hospital after total knee replacement feeling week. Tested positive for COVID 19 and was admitted for PT/OT and given Regeneron infusion as well.
Patient received Shingrix without any active drug. Diluent shot into powder vial and did not check whether or not drug dissolved. The powder did not dissolve in the diluent.
Initial dizziness immediately after vaccine administered; then confusion after leaving facility. Difficulty driving and operating vehicle. Confusion cleared up after a light snack.
Experienced local reactogenicity; This non-serious case was reported by a pharmacist and described the occurrence of reactogenicity event in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix (unknown arm). On an unknown date, an unknown time after receiving Shingrix, the patient experienced reactogenicity event (Verbatim: Experienced local reactogenicity).  The outcome of the reactogenicity event was not reported.   The reporter considered the reactogenicity event to be related to Shingrix.     The company considered the reactogenicity event to be related to Shingrix.   Additional Information: GSK Receipt Date: 23-SEP-2023 The patient age was reported as 6 decades. The reporter reported that the patient mentioned receiving Shingrix and experienced local reactogenicity. The reporter had no additional information except that this person casually mentioned local reactogenicity.
Received vaccine past the 6-hour time expiration; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received vaccine past the 6-hour time expiration) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 15-Mar-2021 at 4:53 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received vaccine past the 6-hour time expiration). On 15-Mar-2021, EXPIRED PRODUCT ADMINISTERED (Received vaccine past the 6-hour time expiration) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.; Sender's Comments: This report refers to a case of Expired Product Administered for mRNA-1273 (Lot #: 014M20A)  with no associated AEs.
Narrative:  Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Pt was 84 years of age, with a PMH significant for hyperlipidemia, HTN, stent for CAD, COPD. No notation of death listed, no recent issues or hospitalizations noted. Limited pt information available.
I came out with rash type lumps all over my body in numerous places 9 days after I had the vaccine. I ignored this thinking it was a bite as that is what they looked like. They grew to large lumps all over my body. I reported this and the dermatologist said it is granuloma annular. I have had adverse reactions to vaccinations in the past such as seizures and sickness etc.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and egnder who on 09-MAR-2015 was vaccinated with a unsupported temperature excursion dose of PNEUMOVAX23 (lot # reported as J49842, expiration date March 2016) (dose not reported), intramusuclar (incorrect product storage). No adverse effects were3 reported. It was unknown if the patient sought medical attention. Additional information has been requested.
(first dose was on 31-Jul-2019 and second dose was on 13-Oct-2019) had a "flare up" on 05-Dec-2020; (first dose was on 31-Jul-2019 and second dose was on 13-Oct-2019) had a "flare up" on 05-Dec-2020; This case was reported by a pharmacist via call center representative and described the occurrence of vaccination failure in a 77-year-old male patient who received Herpes zoster (Shingrix) (batch number 49Y35, expiry date 22nd October 2021) and (batch number 92NA4, expiry date 22nd November 2021) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) (batch number 249DB, expiry date 8th November 2021) and (batch number 92NA4, expiry date 22nd November 2021) for prophylaxis.   On 31st July 2019, the patient received the 1st dose of Shingrix. On 31st July 2019, the 1st dose was an unknown dose. On 13th October 2019, the patient received the 2nd dose of Shingrix. On 13th October 2019, the 2nd dose was an unknown dose. On 5th December 2019, 127 days after receiving Shingrix and 53 days after receiving Shingrix, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. The patient was treated with antivirals nos (Antiviral (Drug Name Unknown)). On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.  Additional details were reported as follows: The patient received 2 doses of vaccine and had a flare up. The reporter consented to follow up.
Client reported feeling tachycardia  and lethargy after his routine bike ride.  He went home to rest, but still felt his heart rate was extremely fast.  At that time, his watch reported that he was in atrial fibrillation.  He called his friend who is a cardiologist and he recommended that he go to the emergency room to get evaluated.
Apprx. 6 hrs after the shots (both my girlfriend and I experience almost identical symptoms) Severe chills, Fever, severe headache, severe muscle pain throughout the body, chest pains, diarrhea, nausea, vertigo, increase heart rate! Two days later and I am still experiencing vertigo, diarrhea, nausea!
Eyes began to burn.  They felt like something was stuck under the lid and scratching them.  It got worse and I was having a hard time seeing.  They felt really dry but at the same time were goopy and sticking together.  Around 9:30pm I came down with a fever and took 400mg of Advil and went to bed.  Woke up at 1am and felt worse so I took 400mg of Advil and put cold towels on my head.  At 11am my fever finally broke and my eyes started to clear up.
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm), FATIGUE (LITTLE TIRED), HEADACHE (Headache), ABDOMINAL PAIN UPPER (Stomach ache) and OROPHARYNGEAL PAIN (Sore throat) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure high and Arthritis. Concomitant products included arthritis medications for Arthritis, high blood pressure medications for Hypertension, BROMAZEPAM (LEXOTAN) for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jan-2021, the patient experienced VACCINATION SITE PAIN (Sore arm) and FATIGUE (LITTLE TIRED). On 20-Jan-2021, the patient experienced HEADACHE (Headache), ABDOMINAL PAIN UPPER (Stomach ache), OROPHARYNGEAL PAIN (Sore throat) and CHEST DISCOMFORT (Chest congestion). On 15-Jan-2021, VACCINATION SITE PAIN (Sore arm) had resolved. On 25-Jan-2021, HEADACHE (Headache), ABDOMINAL PAIN UPPER (Stomach ache), OROPHARYNGEAL PAIN (Sore throat) and CHEST DISCOMFORT (Chest congestion) had resolved. At the time of the report, FATIGUE (LITTLE TIRED) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test negative: negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.